Medicines the European Medicines Agency has recommended for use in the European Union on this topic.
Each number has its full source under its own list below.
59 medicines (authorised now). Newest first. Each links to its EMA page.
Active substance: lenacapavir sodium
Active substance: emtricitabine;rilpivirine hydrochloride;tenofovir alafenamide fumarate
Active substance: emtricitabine;tenofovir alafenamide fumarate
Active substance: cabotegravir
Active substance: lenacapavir sodium
Active substance: fostemsavir trometamol
Active substance: cabotegavir sodium;cabotegravir
Active substance: rilpivirine
Active substance: dolutegravir sodium;lamivudine
Active substance: doravirine;lamivudine;tenofovir disoproxil fumarate
Active substance: doravirine
Active substance: bictegravir;emtricitabine;tenofovir alafenamide;fumarate
Active substance: dolutegravir sodium;rilpivirine hydrochloride
Active substance: efavirenz;emtricitabine;tenofovir disoproxil succinate
Active substance: darunavir
Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.
Countries side by side on public measures for this topic.
Worldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View reportAcuitas market sizes and forecasts are only in our full reports. How we use public data.